Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther G Gerrits

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Nephrology and Hypertension|September 17, 2010
Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney diseaseAndries J Smit, Esther G Gerrits
JAMA Internal Medicine|March 3, 2015
Mortality trends in diabetes mellitusEsther G Gerrits, Gijs W Landman, Henk J Bilo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2008
AGEs, autofluorescence and renal functionEsther G Gerrits, Andries J Smit, Henk J G Bilo
Obesity Surgery|July 5, 2003
Contraceptive treatment after biliopancreatic diversion needs consensusEsther G Gerrits, Robrecht Ceulemans, Robrecht van Hee, et al.
World Journal of Diabetes|August 13, 2015
Limited joint mobility syndrome in diabetes mellitus: A minireviewEsther G Gerrits, Gijs W Landman, Leonie Nijenhuis-Rosien, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9)Esther G Gerrits, Helen L Lutgers, Nanne Kleefstra, et al.
Diabetes Care|November 28, 2007
Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complicationsEsther G Gerrits, Helen L Lutgers, Nanne Kleefstra, et al.
Nephron Extra|July 20, 2012
Skin autofluorescence: a pronounced marker of mortality in hemodialysis patientsEsther G Gerrits, Helen L Lutgers, Gertie H W Smeets, et al.
Plos One|August 29, 2009
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)Helen L Lutgers, Esther G Gerrits, Wim J Sluiter, et al.
Plos One|March 4, 2014
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28)Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Nephrology and Hypertension|September 17, 2010
Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney diseaseAndries J Smit, Esther G Gerrits
JAMA Internal Medicine|March 3, 2015
Mortality trends in diabetes mellitusEsther G Gerrits, Gijs W Landman, Henk J Bilo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2008
AGEs, autofluorescence and renal functionEsther G Gerrits, Andries J Smit, Henk J G Bilo
Obesity Surgery|July 5, 2003
Contraceptive treatment after biliopancreatic diversion needs consensusEsther G Gerrits, Robrecht Ceulemans, Robrecht van Hee, et al.
World Journal of Diabetes|August 13, 2015
Limited joint mobility syndrome in diabetes mellitus: A minireviewEsther G Gerrits, Gijs W Landman, Leonie Nijenhuis-Rosien, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9)Esther G Gerrits, Helen L Lutgers, Nanne Kleefstra, et al.
Diabetes Care|November 28, 2007
Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complicationsEsther G Gerrits, Helen L Lutgers, Nanne Kleefstra, et al.
Nephron Extra|July 20, 2012
Skin autofluorescence: a pronounced marker of mortality in hemodialysis patientsEsther G Gerrits, Helen L Lutgers, Gertie H W Smeets, et al.
Plos One|August 29, 2009
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)Helen L Lutgers, Esther G Gerrits, Wim J Sluiter, et al.
Plos One|March 4, 2014
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28)Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, et al.
Pageof 1